Jinghua Pharmaceutical Group Co., Ltd. (SHE:002349)

SHE:002349 Revenue

Jinghua Pharmaceutical Group had revenue of 379.76M CNY in the quarter ending March 31, 2026, with 4.46% growth. This brings the company's revenue in the last twelve months to 1.48B, up 5.56% year-over-year. In the year 2025, Jinghua Pharmaceutical Group had annual revenue of 1.46B with 4.13% growth.

• Revenue (ttm): 1.48B
• Revenue Growth: +5.56%
• P/S Ratio: 3.63
• Revenue / Employee: 1.01M
• Employees: 1,462
• Market Cap: 5.36B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.46B	57.87M	4.13%
Dec 31, 2024	1.40B	-109.66M	-7.25%
Dec 31, 2023	1.51B	-61.31M	-3.90%
Jan 1, 2023	1.57B	215.19M	15.85%
Jan 1, 2022	1.36B	76.51M	5.97%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 9, 2026

Data Sources Report a data error